Genocea Provides Fourth Quarter 2020 Corporate Update
GEN-011 and GEN-009 clinical trials continue to advance ATLASTMstimulatory antigen and inhibitory antigen (InhibigenTM) identification profiled in Cancer Discovery Announcing...
Staff
InflaRx Announces Presentation of New C5a and Vilobelimab (IFX-1) Data from Phase IIB SHINE Study at the 2021 Virtual European Hidradenitis Suppurativa Foundation Conference
Significantly elevated baseline C5a levels occur in hidradenitis suppurativa (HS) patientsVilobelimab dose-dependently suppresses C5a levels over time accompanied by the...
Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer
Molecular Templates to receive $70 million upfront payment with potential for additional milestone and royalty payments on future salesAUSTIN, Texas,...
Eve & Co Completes First Shipment of Dried Flower Products to the Province of New Brunswick
STRATHROY, Ontario, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE;...
Plus Therapeutics to Participate in BIO CEO & Investor Digital Conference
Buzz of BIO Public Therapeutic Biotech Winner AUSTIN, Texas, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the...
Biogen and LabCentral Award Two Golden Tickets to Local and Innovative Science Startups
Golden Tickets winners Bolden Therapeutics and Seranova Bio will have access to a state-of-the-art lab facilities at LabCentral with mentorship...
Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer
WILMETTE, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed...
MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte
ROCKVILLE, MD, Feb. 11, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing...
Modern Health Gains Unicorn Status After $74 Million Series D at $1.17 Billion Valuation
Led by Founders Fund, Funding Round Brings Total Investment to Over $172 Million To Support Accelerated Growth & Rising Demand...
BioCryst to Report Fourth Quarter and Full Year 2020 Financial Results on February 25
RESEARCH TRIANGLE PARK, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company...
Revive Therapeutics Provides Update on Cannabinoid Pharmaceuticals Program
TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty...
C4 Therapeutics to Participate in BMO BioPharma Spotlight Series
WATERTOWN, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new...
Philips Named Top Place to Work on Forbes’ “America’s Best Employers of 2021” List
Health technology leader continues to climb list, up 21 spots from last ranking CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX:...
NextGen® Patient Experience Platform Adopted by Lone Star Circle of Care Network
Prominent Community Health Centers in Texas Improve Patient Engagement with Well-Integrated Capabilities ATLANTA--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a...
Live Remote Supervision of Neuroendovascular Surgery Enabled by Olympus MedPresence®
Virtual Presence Solution Provides OR Access to Proctor Required to Oversee Critical Aneurysm Implant Procedure in New Device Trial CENTER...
Saint Peter’s University Hospital Expands Partnership with CarePort® to Support Compliance with CMS’s Patient Event Notification Requirements
New Jersey hospital selects CarePort Interop to deliver new electronic notifications to relevant stakeholders, gaining access to the nation’s largest...
Intersect ENT Announces Launch of the New Straight Delivery System Packaged with the PROPEL® Mini Sinus Implant
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to...
Axonics® to Participate in the SVB Leerink Global Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable...
U.S. Physicians Can Now Order Lucira Health Self-Administered, Lab Quality, COVID-19 Molecular Test for Home or Office
--- Lab-quality results in 30 minutes or less --- EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), today announced that U.S....
DocMorris goes European: new branding for marketplaces in Spain and France
Heerlen/Barcelona, 11.02.2021 – DocMorris is taking the next step in implementing its new brand architecture on the way to becoming...